Novo Nordisk beats profit estimates, lifts outlook slightly


COPENHAGEN, Aug 5 (Reuters) - Denmark's Novo Nordisk NOVOb.CO posted a better-than-expected quarterly operating profit on Thursday and slightly lifted its full-year earnings outlook, the company said.

The world's top maker of diabetes drugs posted a second-quarter operating profit of 13.8 billion Danish crowns ($2.20 billion), compared to an average 13.31 billion expected by analysts in a Refinitiv poll. L8N2F61E2

The company now expects annual operating profit growth in the range of 2-5%, up from an earlier estimate of 1-5% growth.

($1 = 6.2705 Danish crowns)

(Reporting by Nikolaj Skydsgaard Editing by Shri Navaratnam)


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.